Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bioceres Crop Solutions Q2 Sales $106.500M Miss $129.500M Estimate, Net Income $0.6M Down From $1.2M YoY

Author: Benzinga Newsdesk | February 12, 2025 02:35am
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly sales of $106.500 million which missed the analyst consensus estimate of $129.500 million by 17.76 percent. This is a 24.09 percent decrease over sales of $140.300 million the same period last year.

Posted In: BIOX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist